在癌症患者中,大麻应用于厌食症吗?
Mellar Davis1, Claude Cyr2, Gregory B Crawford3
1Professor of Palliative Medicine (M.D.), Geisinger Medical Center, Danville, Pennsylvania, USA.
Journal of pain and symptom management
|January 25, 2024
概括
尽管人们普遍认为,大麻并不能显著改善厌食症-缓解症综合征患者的食欲. 研究表明,对益处的证据有限,研究中使用的合成产品并不反映常见使用情况.
科学领域:
- 医学大麻研究 医学大麻研究
- 瘤学 支持性护理 支持性护理
- 胃肠病学 胃肠病学
背景情况:
- 患有癌症等严重疾病的患者往往会经历食欲丧失 (厌食症-缓解症综合征).
- 大麻被普遍认为可以刺激食欲 ("吃饭"),导致患者寻求缓解.
- 关于大麻在临床环境中刺激食欲的疗效,科学数据有限.
研究的目的:
- 评估大麻在改善厌食症-食症综合征患者的食欲方面的有效性.
- 审查现有的关于大麻和食欲的随机对照试验 (RCT).
- 将研究结果与大麻作为食欲兴奋剂的普遍看法进行比较.
主要方法:
- 现有随机对照试验 (RCT) 调查大麻对食欲的审查.
- 对专注于厌食症-缓解症综合征和大麻使用的研究进行分析.
- 考虑研究中使用的大麻产品类型与普通患者使用的类型.
主要成果:
- 很少有小型RCT研究了大麻对食欲的作用,但没有显示出统计学上显著的益处.
- 一项研究表明,可能会改善食物的味道.
- 研究经常使用合成大麻产品,与通常使用的全花产品不同.
结论:
- 目前的证据不支持常规使用大麻治疗厌食症-缓解症综合征.
- 大麻的不良影响和药物相互作用需要进一步调查.
- 专家对医用大麻的食欲丧失认证意见各不相同,有些人认为它适用于特定的癌症患者.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
278
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
278
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Anorexia Nervosa
70
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
70
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


